Fostamatinib for Treating Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Adults
Status:
NOT_YET_RECRUITING
Trial end date:
2026-10-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety and efficacy of fostamatinib in hospitalized adult participants with acute respiratory distress syndrome (ARDS).
Phase:
PHASE2
Details
Lead Sponsor:
Inova Health Care Services
Collaborators:
Biomedical Advanced Research and Development Authority Rigel Pharmaceuticals